Maximum quantity allowed is 999
Please select the quantity
CAS RN: 259793-96-9 | Product Number: F1296
Favipiravir
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- T-705
- 6-Fluoro-3-hydroxy-2-pyrazinecarboxamide
- 6-Fluoro-3-hydroxypyrazine-2-carboxamide
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 25MG |
$146.00
|
4 | 36 | It can be shipped in about 3-4 weeks after ordering | |
| 100MG |
$432.00
|
≥40 | 15 | It can be shipped in about 3-4 weeks after ordering |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
Supplemental Product Information:
This product is a sample for RUO (research use only). Do not use this product for any purpose other than testing and research.
| Product Number | F1296 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__5H__4FN__3O__2 = 157.10 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Air Sensitive,Heat Sensitive |
| Packaging and Container | 100MG-Glass Bottle with Plastic Insert (View image), 25MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 259793-96-9 |
| Reaxys Registry Number | 9697246 |
| MDL Number | MFCD12032148 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Melting point | 190.0 to 194.0 °C |
Properties (reference)
| Melting Point | 192 °C |
| Solubility (slightly sol. in) | Methanol |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H361 : Suspected of damaging fertility or the unborn child. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
Related Laws:
| RTECS# | UQ2281100 |
Transport Information:
| H.S.code* | 2933.99-000 |
Application
Favipiravir: A Potent and Selective Viral RNA Polymerase Inhibitor
Favipiravir (T-705) is an antiviral agent developed by Shiraki, et al. It has been found to have potent and selective inhibitory activity against RNA-dependent RNA polymerase of RNA viruses, such as influenza A, B, and C viruses.1-4) Its ribose-5’-triphosphate is the active metabolite, and it is recognized by virus RNA polymerase as a substrate competing with guanosine 5'-triphosphate (GTP), giving inhibition of viral RNA synthesis. On the other hand, it has been pointed out that favipiravir has a risk for teratogenicity and embryotoxicity.4) Recently, favipiravir has been also reported to show potential anti Ebola virus and coronavirus (SARS-CoV-2) activities.4-7) For your reference, T-1105 [H1485], an antiviral agent, is an analog replacing the 6-fluoro atom to hydrogen. (The product is for research purpose only.)
References
- 1) In vitro and in vivo activities of anti-influenza virus compound T-705
- 2) Mechanism of action of T-705 against influenza virus
- 3) Favipiravir (T-705), a novel viral RNA polymerase inhibitor (a review)
- 4) Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase (a review)
- 5) Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model
- 6) Discovering drugs to treat coronavirus disease 2019 (COVID-19).
- 7) Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
Articles/Brochures
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.